Atlas Trials

A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

Clinical trial NCT00236561 · COMPLETED

Trial details

NCT number
NCT00236561
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
MigraineCommon MigraineClassic MigraineHeadache
Start date
2001-04-01
Enrollment
786

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.